Expression of MMP-13 is associated with invasion and metastasis of papillary thyroid carcinoma

European Review for Medical and Pharmacological Sciences

Volumn 17, Issue 4, 2013, Pages 427-435

  Wang, J R ^a   Li, X H ^a   Gao, X J ^a   An, S C ^a   Liu, H ^a   Liang, J ^a   Zhang, K ^a   Liu, Z ^a   Wang, J ^a   Chen, Z ^a   Sun, W ^a  

^a QINGDAO UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

Matrix metalloproteinase 13; Metastasis; Papillary thyroid carcinomas

Indexed keywords

COLLAGENASE 3;

ARTICLE; CANCER RECURRENCE; CELL MIGRATION; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; METASTASIS; PROTEIN EXPRESSION; THYROID CARCINOMA; TUMOR INVASION; TUMOR VOLUME;

ADULT; ANIMALS; BLOTTING, WESTERN; CARCINOMA; CASE-CONTROL STUDIES; CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; CELL MOVEMENT; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION; GENE SILENCING; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MATRIX METALLOPROTEINASE 13; MICE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NEOPLASM TRANSPLANTATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; THYROID GLAND; THYROID NEOPLASMS;

EID: 84878591708     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. WARTOFSKY L. Increasing world incidence of thyroid cancer: increased detection or higher radiation exposure? Hormones 2010; 9: 103-108.
2. ROH JL, PARK JY, PARK CI. Total thyroidectomy plus neck dissection in differentiated papillary thyroid carcinoma patients: pattern of nodal metastasis, morbidity, recurrence, and postoperative levels of serum parathyroid hormone. Ann Surg 2007; 245: 604-610.
3. LEE YS, LIM YS, LEE JC, WANG SG, KIM IJ, LEE BJ. Clinical implication of the number of central lymph node metastasis in papillary thyroid carcinoma: preliminary report.World J Surg 2010; 34: 2558-2563.
4. SCHLUMBERGER MJ. Papillary and follicular thyroid carcinoma. N Engl J Med 1998; 338: 297-306.
5. FAGIN JA, TUTTLE RM, PFISTER DG. Harvesting the low-hanging fruit: kinase inhibitors for therapy of advanced medullary and nonmedullary thyroid cancer. J Clin Endocrinol Metab 2010; 95: 2621-2624.
6. KATIYAR SK. Matrix metalloproteinases in cancer metastasis: molecular targets for prostate cancer prevention by green tea polyphenols and grape seed proanthocyanidins. Endocr Metab Immune Disord Drug Targets 2006; 6: 17-24.
7. FREIJE JM, BALBÍN M, PENDÁS AM, SÁNCHEZ LM, PUENTE XS, LÓPEZ-OTÍN C. Matrix metalloproteinases and tumor progression. Adv Exp Med Biol 2003; 532: 91-107.
8. PRICE JT, THOMPSON EW. Mechanisms of tumour invasion and metastasis: emerging targets for therapy. Expert Opin Ther Targets 2002; 6: 217-233.
9. KUMMER NT, NOWICKI TS, AZZI JP, REYES I, IACOB C, XIE S, SWATI I, DARZYNKIEWICZ Z, GOTLINGER KH, SUSLINA N, SCHANTZ S, TIWARI RK, GELIEBTER J. Arachidonate 5 lipoxygenase expression in papillary thyroid carcinoma promotes invasion via MMP-9 induction. J Cell Biochem 2012; 113: 1998-2008.
10. BAUERLE KT, SCHWEPPE RE, HAUGEN BR. Inhibition of nuclear factor-kappa B differentially affects thyroid cancer cell growth, apoptosis, and invasion. Mol Cancer 2010; 9: 117.
11. FREIJE JM, DIEZ II, BALBIN M. Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas. J Biol Chem 1994; 269: 16766-16773.
12. ZHANG B, CAO X, LIU Y, CAO W, ZHANG F, ZHANG S, LI H, NING L, FU L, NIU Y, NIU R, SUN B, HAO X. Tumorderived matrix metalloproteinase-13 (MMP-13) correlates with poor prognoses of invasive breast cancer. BMC Cancer 2008; 28: 8:83.
13. YAMADA T, OSHIMA T, YOSHIHARA K, TAMURA S, KANAZAWA A, INAGAKI D, YAMAMOTO N, SATO T, FUJII S, NUMATA K, KUNISAKI C, SHIOZAWA M, MORINAGA S, AKAIKE M, RINO Y, TANAKA K, MASUDA M, IMADA T. Overexpression of MMP-13 gene in colorectal cancer with liver metastasis. Anticancer Res 2010; 30: 2693-2699.
14. MÄKINEN LK, HÄYRY V, ATULA T, HAGLUND C, KESKISÄNTTI H, LEIVO I, MÄKITIE A, HAGSTRÖM J. Prognostic significance of matrix metalloproteinase-2, -8, -9, and -13 in oral tongue cancer. J Oral Pathol Med 2012; 41: 394-399.
15. KOMINSKY SL, DOUCET M, THORPE M, WEBER KL. MMP-13 is over-expressed in renal cell carcinoma bone metastasis and is induced by TGF-beta1. Clin Exp Metastasis 2008; 25: 865-870.
16. HSU CP, SHEN GH, KO JL. Matrix metalloproteinase-13 expression is associated with bone marrow microinvolvement and prognosis in non-small cell lung cancer. Lung Cancer 2006; 52: 349-357.
17. CORTE MD, GONZALEZ LO, CORTE MG, QUINTELA I, PIDAL I, BONGERA M, VIZOSO F. Collagenase-3 (MMP-13) expression in cutaneous malignant melanoma. Int J Biol Markers 2005; 20: 242-248.
18. LUUKKAA M, VIHINEN P, KRONQVIST P, VAHLBERG T, PYRHÖNEN S, KÄHÄRI VM, GRÉNMAN R. Association between high collagenase-3 expression levels and poor prognosis in patients with head and neck cancer. Head Neck 2006; 28: 225-234.
19. INOUE A, TAKAHASHI H, HARADA H, KOHNO S, OHUE S, KOBAYASHI K, YANO H, TANAKA J, OHNISHI T. Cancer stem-like cells of glioblastoma characteristically express MMP-13 and display highly invasive activity. Int J Oncol 2010; 37: 1121-1131.
20. SOBIN L, WITTEKIND C. Head and neck tumours: thyroid gland. In TNM Classification of Malignant Tumours, edn 5, pp 47-50. New York: Wiley-Liss, Inc., 1997.
21. VICKERY AL JR, CARCANGIU ML, JOHANNESSEN JV, SOBRINHO- SIMOES M. Papillary carcinoma. Semin Diagn Pathol 185; 2: 90-100.
22. NOWICKI TS, KUMMER NT, IACOB C, SUSLINA N, SCHAEFER S, SCHANTZ S, SHIN E, MOSCATELLO AL, TIWARI RK, GELIEBTER J. Inhibition of uPAR and uPA reduces invasion in papillary thyroid carcinoma cells. Laryngoscope 2010; 120: 1383-1390.
23. KAJITA S, RUEBEL KH, CASEY MB, NAKAMURA N, LLOYD RV. Role of COX-2, thromboxane A2 synthase, and prostaglandin I2 synthase in papillary thyroid carcinoma growth.Mod Pathol 2005; 18: 221-227.
24. FREIJE JM, DÍEZ-ITZA I, BALBÍN M, SÁNCHEZ LM, BLASCO R, TOLIVIA J, LÓPEZ-OTÍN C. Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas. J Biol Chem 1994; 269: 16766-16773.
25. VARGOVÁ V, PYTLIAK M, MECHÍROVÁ V. Matrix metalloproteinases. EXS 2012; 103: 1-33.
26. BRUMMELKAMP TR, BERNARDS R, AGAMI R. Stable suppression of tumorigenicity by virus-mediated RNA interference. Cancer Cell 2002; 2: 243-247.
27. HINGORANI SR, JACOBETZ MA, ROBERTSON GP, HERLYN M, TUVESON DA. Suppression of BRAF (V599E) in human melanoma abrogates transformation. Cancer Res 2003; 63: 5198-5202.
28. HERRMANN J, ABRISS B, VAN DE LEUR E, WEISKIRCHEN S, GRESSNER AM, WEISKIRCHEN R. Comparative analysis of adenoviral transgene delivery via tail or portal vein into rat liver. Arch Virol 2004; 149: 1611-1617.